Results 61 to 70 of about 1,320,363 (167)

Integration of Raman Spectroscopy and Metabolomics for Early Breast Cancer Detection and Classification

open access: yesCancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Breast cancer, now the fourth leading cause of cancer‐related mortality worldwide, necessitates early detection for improved clinical outcomes. Conventional histopathology, though widely used, is invasive and subjective, limiting its utility in early‐stage diagnosis.
Xue Li   +4 more
wiley   +1 more source

Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials

open access: yesCancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Concomitant medications (CMs) influence outcomes in patients receiving immune checkpoint inhibitors (ICIs), but their impact in sarcoma remains undefined. We assessed the association between CM use and ICI outcomes in patients with advanced or metastatic sarcoma. Methods This pooled analysis included patients from seven investigator‐
Adel Shahnam   +16 more
wiley   +1 more source

Clinical presentation and radiologic imaging findings of phyllodes tumors: benign and borderline/malignant phyllodes tumors [version 2; peer review: 2 approved]

open access: yesF1000Research
Background Phyllodes tumor is a rare fibroepithelial neoplasm of the breast, which is classified histologically as benign, borderline, or malignant. Accurate preoperative diagnosis allows the correct surgical planning and reoperation avoidance. Objective
Amolchaya Kwankua   +2 more
doaj   +1 more source

Ruptured phyllodes tumors of the breast: a comprehensive case series and literature review on clinical challenges

open access: yesWorld Journal of Surgical Oncology
Phyllodes tumors are rare fibroepithelial breast neoplasms, predominantly affecting women aged 35 to 55. While most phyllodes tumors are manageable, those exceeding 10 cm, termed giant phyllodes tumors, can lead to rare complications such as breast ...
Chularat Duangkaew   +4 more
doaj   +1 more source

Beyond the Triple‐Negative Label: A Case Report on Metaplastic Breast Carcinoma

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Metaplastic breast carcinoma (MpBC) is a rare, aggressive breast malignancy with poorer prognosis than conventional subtypes. Predominant hematogenous spread, frequent triple‐negative phenotype, chemoresistance, rarity, and poorly defined treatment protocols render MpBC a significant diagnostic and therapeutic challenge for oncologists in ...
Samana Oli   +8 more
wiley   +1 more source

Prostatic stromal tumors with uncertain malignant potential: A scoping review of clinical challenges and management strategies

open access: yesUroPrecision, Volume 4, Issue 2, Page 88-97, June 2026.
Abstract Prostatic stromal tumor of uncertain malignant potential (STUMP) is a rare neoplasm arising from specialized prostatic stromal cells with a broad range of histologic patterns and unpredictable clinical behavior. It is often challenging to distinguish STUMP from prostatic stromal sarcoma due to morphological similarities, necessitating specific
Ibrahim A. Khalil   +7 more
wiley   +1 more source

Phyllodes Tumor on Male Breast: A Literature Review

open access: yesIndonesian Journal of Cancer
Background: Phyllodes tumor is a neoplasm from the fibroepithelial lesion and is rare to be found. Hence, there are some case reports that phyllodes tumor also can be found in the male breast. From 1990 until 2020, 13 articles show the phyllodes tumor in
Naufal Dzulhijar, Muhammad Yamsun
doaj   +1 more source

Breast Cancer Multi‐Disciplinary Team Meetings in a Resource‐Constrained System: Are Patients Receiving the Treatment Recommended?

open access: yesWorld Journal of Surgery, Volume 50, Issue 6, Page 1481-1486, June 2026.
A total of 556 patients were included in the analyses. Most patients (88%) received primary treatment aligned with the MDT's recommendations. The highest level of concordance was seen in those with early breast cancer who were recommended to have primary surgery (94%), and the lowest in those with metastatic disease.
Nerushka Naidoo   +5 more
wiley   +1 more source

Giant phyllodes tumor of the breast: a clinical observation [PDF]

open access: yes, 2018
CSF “Galaxia”, IMSP IO a RM, Conferința Științifică „Centrul Medical «Galaxia» la 20 de ani”Se prezinta caz de observare clinica si tratament a tumorii gigante filoide (TF). Tumorile phyllodes sunt leziuni fibroepiteliale rare formate din tesut epitelial
Jitaru, Natalia, Botnariuc, Natalia
core   +1 more source

Home - About - Disclaimer - Privacy